论文信息 - Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study - 字舞流文

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

M. Netea | J. Cerhan | R. ter Horst | K. Hemminki | S. de Sanjosé | S. Slager | A. Försti | D. Campa | F. Canzian | Yang Li | S. Landi | R. Marasca | M. Luppi | J. Llorca | T. Chen-Liang | A. Jerez | M. Cañadas-Garre | H. Thomsen | B. Espinet | M. López-Nevot | A. Norman | Y. Benavente | M. Alcoceba | A. Butrym | R. Marcos-Gragera | D. Casabonne | J. Sainz | M. Jurado | R. Maffei | J. Rodríguez-Sevilla | F. Hernández-Mohedo | Alyssa I Clay-Gilmour | Y. Niazi | M. García‐Álvarez | Sonja L. Berndt | V. Moreno | A. Puiggros | M. Giaccherini | A. Macauda | Paloma García-Martín | P. González-Sierra | J. Maldonado | Ana Moñiz Díez | Antonio José Cabrera Serrano | Gonzalo Blanco | Irene Gámez | J. J. Rodríguez-Sevilla | Alyssa I. Clay-Gilmour | Sonja Berndt | M. García-Álvarez

[1] Ya Zhang,et al. Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia , 2021, Frontiers in Oncology.

[2] A. Pettitt,et al. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia , 2021, Nature communications.

[3] G. Martinelli,et al. Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients , 2018, Journal of Translational Medicine.

[4] A. Spathis,et al. Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia. , 2017, Leukemia research.

[5] D. Rossi,et al. Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment. , 2016, Blood advances.

[6] Paolo Vineis,et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia , 2016, Nature Communications.

[7] L. Gordon,et al. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL) , 2015, Cancer biology & therapy.

[8] L. Lagneaux,et al. HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance , 2012, Epigenetics.

[9] D. Reinhardt,et al. The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells , 2012, Haematologica.

[10] Reuben Thomas,et al. Post-GWAS Functional Characterization of Susceptibility Variants for Chronic Lymphocytic Leukemia , 2012, PloS one.

[11] D. Rossi,et al. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. , 2011, Blood.

[12] R. Fanin,et al. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B‐CLL) cells , 2005, Journal of cellular physiology.

[13] S. Roncella,et al. Heterogeneous Expression of Interleukin-18 and Its Receptor in B-Cell Lymphoproliferative Disorders Deriving from Naive, Germinal Center, and Memory B Lymphocytes , 2004, Clinical Cancer Research.

[14] L. Ginaldi,et al. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. , 1998, Journal of clinical pathology.

[15] E. Jabłońska,et al. TRAIL receptors in the serum of patients with B-cell chronic lymphocytic leukemia. , 2008, Neoplasma (Bratislava).